EXAGEN INC. — Director's Dealing 2020

Mar 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2020-03-24

Reporting Person: Zack Debra (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-24	Stock Option (Right to Buy)	$13.44	A	100000	Acquired	2030-03-23	Common Stock (100000)	Direct

Footnotes

F1: The option is exercisable as it vests. 25% of the shares subject to the option vest on March 24, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date